0 Комментарии
0 Поделились
286 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Andersen Disease Treatment Market Size and Revenue Forecast to 2033According to the latest report published by Data Bridge Market Research, the Andersen Disease Treatment Market The global andersen disease treatment market size was valued at USD 1.27 billion in 2025 and is expected to reach USD 2.05 billion by 2033, at a CAGR of 6.20% during the forecast period Market insights provided in the most excellent Andersen...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Bariatric surgery: drastic, but it cures metabolic syndrome in 80% of patientsLet's be real: surgery seems extreme. But for people with severe obesity (BMI >40) or BMI >35 with complications, bariatric surgery (gastric bypass, sleeve) is the most effective treatment. The metabolic syndrome market forecast shows that surgery is the fastest‑growing treatment segment, with a CAGR above 9%. Why? Because it doesn't just reduce weight — it changes gut...0 Комментарии 0 Поделились 748 Просмотры 0 предпросмотр
-
Bariatric surgery: drastic, but it cures metabolic syndrome in 80% of patientsLet's be real: surgery seems extreme. But for people with severe obesity (BMI >40) or BMI >35 with complications, bariatric surgery (gastric bypass, sleeve) is the most effective treatment. The metabolic syndrome market forecast shows that surgery is the fastest‑growing treatment segment, with a CAGR above 9%. Why? Because it doesn't just reduce weight — it changes gut...0 Комментарии 0 Поделились 697 Просмотры 0 предпросмотр
-
PPAR Agonist Product Types: Comparison of Brand Offerings and Strategy for Market Share CapturePPAR Agonists (Product types) remain foundational pharmacological agents in the management of specific components of Metabolic Syndrome, particularly in addressing Dyslipidemia Management (Use cases) and insulin resistance. These agents target nuclear receptors involved in lipid and glucose metabolism, offering a precise mechanism of action for cardiovascular risk reduction....0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр